Skip to main content
Signal8

MANGOCEUTICALS, INC. (MGRX)

Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.

Sector: Services-Misc Health & Allied Services, NEC

Industry: Medical - Healthcare Information Services

Mangoceuticals, Inc. logo

Mangoceuticals, Inc.

NASDAQ:MGRXHealthcare
-0.19%$0.1600
CLOSED
AH$0.1654+3.38%vs close
Mkt Cap$3.56M
EV-
Float17.27M
O/S22.22M
VOL409K sh
$ Vol$65K
RVOL0.52×
Inst Own7.5%
SI0.3%
Net Cash/Sh-
Dilution
Mangoceuticals, Inc. logoNASDAQ:MGRXClosed$0.1600-0.19%

MANGOCEUTICALS, INC. (MGRX) dilution facts from SEC filings

Snapshot as of Sep 30, 2026, built from 29 SEC filings.

Shelf registration
S-3 filed Jun 13, 2025, effective Jun 24, 2025
Source: 10-Q filed Nov 16, 2026
At-the-market (ATM) program
No active program in the filings reviewed
Warrants outstanding
10 warrant series recorded as outstanding
Most recent offering
Registered direct offering, closed Oct 9, 2026
Source: 10-Q filed Nov 16, 2026

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro